Pfizer Inc. (NYSE:PFE) declared on Tuesday that it has a 25% increased in Q2 net income due to aggressive cost reducing and lower restructuring and other charges, shaking off the projected decline in revenue from generic competition to cholesterol ...

Pfizer Inc. (PFE) (PFE), the world's largest drugmaker, put in place the last piece of its plan to refocus the company on developing new drugs, announcing it would start the separation of its animal-health business this month.

U.S. stocks retreated on Tuesday on lingering media report that Europe would take bold steps to curb its debt crisis, overshadowing an increase in U.S.

Pfizer beats Street; shares flirt with five-year high. Published: Tuesday, 31 Jul 2012 | 2:14 PM ET. Text Size. NEW YORK (Reuters) - Pfizer Inc <PFE.

With comments from Germany depleting optimism ahead of the European Central Bank (ECB) meeting, the major indexes have drifted into the red today.

Dow stocks are mix today with nearly half of the total 30 components moving up at last check. The Dow Jones Industrial Average (INDEXDJX:.

The U.S. Food and Drug Administration may take longer than expected to review Pfizer Inc.'s (PFE) application to market a new treatment for rheumatoid arthritis, the drug maker's chief said Tuesday.

Pfizer Inc. (PFE) (PFE) said its rheumatoid arthritis treatment tofacitinib, one of the company's leading experimental drugs, was more effective than an older treatment in a large-scale study.

On Tuesday July 31, one of the biggest names in the healthcare and drug manufacturing sector, Pfizer (PFE) will report earnings, and expectations are high.